Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 26;12(15):2621-2626.
doi: 10.12998/wjcc.v12.i15.2621.

Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report

Affiliations
Case Reports

Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report

Yu Chen et al. World J Clin Cases. .

Abstract

Background: Acute upper gastrointestinal bleeding is a common medical emergency that has a 10% hospital mortality rate. According to the etiology, this disease can be divided into acute varicose veins and nonvaricose veins. Bleeding from esophageal varices is a life-threatening complication of portal hypertension. Portal hypertension is a clinical syndrome defined as a portal venous pressure that exceeds 10 mmHg. Cirrhosis is the most common cause of portal hypertension, and thrombosis of the portal system not associated with liver cirrhosis is the second most common cause of portal hypertension in the Western world. Primary myeloproliferative disorders are the main cause of portal venous thrombosis, and somatic mutations in the Janus kinase 2 gene (JAK2 V617F) can be found in approximately 90% of polycythemia vera, 50% of essential thrombocyrosis and 50% of primary myelofibrosis.

Case summary: We present a rare case of primary myelofibrosis with gastrointestinal bleeding as the primary manifestation that presented as portal-superior-splenic mesenteric vein thrombosis. Peripheral blood tests revealed the presence of the JAK2 V617F mutation. Bone marrow biopsy ultimately confirmed the diagnosis of myelofibrosis (MF-2 grade).

Conclusion: In patients with acute esophageal variceal bleeding due to portal hypertension and vein thrombosis without cirrhosis, the possibility of myeloproliferative neoplasms should be considered, and the JAK2 mutation test should be performed.

Keywords: Acute esophageal variceal bleeding; Case report; JAK2 V617F mutation; Myelofibrosis; Portal hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: We declare that we have no financial and personal relationships with other people ororganizations that can inappropriately influence our work, there is no professional or other personal interest of anynature or kind in any product, service and/or company that could be construed as influencing the position presentedin, or the review of, the manuscript entitled.

Figures

Figure 1
Figure 1
Examinations images. A and B: Contrast-enhanced abdominal computerized tomography image demonstrating extensive splanchnic vein thrombosis involving the portal, splenic, and superior mesenteric veins; C amd D: Bone marrow biopsy revealed that myelofibrosis (MF-2 grade) was accompanied by a significant increase in platelet count; E and F: An emergency endoscopy showed esophagogastric varices (F3CbRc+Les, severe). A white thrombus was detected on the middle of the esophageal varices.

Similar articles

References

    1. Acute upper gastrointestinal bleeding in over 16s: management. London: National Institute for Health and Care Excellence (NICE); 2016 Aug- - PubMed
    1. Valla DC, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West. J Gastroenterol Hepatol. 2002;17 Suppl 3:S224–S227. - PubMed
    1. Barbui T, Ghirardi A, Carobbio A, Masciulli A, Carioli G, Rambaldi A, Finazzi MC, Bellini M, Rumi E, Vanni D, Borsani O, Passamonti F, Mora B, Brociner M, Guglielmelli P, Paoli C, Alvarez-Larran A, Triguero A, Garrote M, Pettersson H, Andréasson B, Barosi G, Vannucchi AM. Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood Cancer J. 2022;12:156. - PMC - PubMed
    1. Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921–4928. - PubMed
    1. Spivak JL. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med. 2010;152:300–306. - PubMed

Publication types